Publication:
Recommendations for follow-up of colorectal cancer survivors.

Simple item page
dc.contributor.authorVera, R
dc.contributor.authorAparicio, J
dc.contributor.authorCarballo, F
dc.contributor.authorEsteva, M
dc.contributor.authorGonzález-Flores, E
dc.contributor.authorSantianes, J
dc.contributor.authorSantolaya, F
dc.contributor.authorFernández-Cebrián, J M
dc.date.accessioned2023-01-25T10:31:02Z
dc.date.available2023-01-25T10:31:02Z
dc.date.issued2019-02-14
dc.description.abstractColorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.
dc.identifier.doi10.1007/s12094-019-02059-1
dc.identifier.essn1699-3055
dc.identifier.pmid30762206
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-019-02059-1.pdf
dc.identifier.urihttp://hdl.handle.net/10668/13563
dc.issue.number10
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.number1302-1311
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCancer survivors
dc.subjectCare coordination
dc.subjectMonitoring
dc.subjectQuality of life
dc.subjectSurveillance
dc.subjectTreatment sequelae
dc.subject.meshAntineoplastic Agents
dc.subject.meshCancer Survivors
dc.subject.meshCarcinoembryonic Antigen
dc.subject.meshColonic Neoplasms
dc.subject.meshColonoscopy
dc.subject.meshContinuity of Patient Care
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLiver Neoplasms
dc.subject.meshLung Neoplasms
dc.subject.meshMale
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshNeoplasm Staging
dc.subject.meshOxaliplatin
dc.subject.meshPatient Care Team
dc.subject.meshPopulation Surveillance
dc.subject.meshPostoperative Complications
dc.subject.meshPrimary Prevention
dc.subject.meshRadiotherapy
dc.subject.meshRectal Neoplasms
dc.subject.meshSecondary Prevention
dc.subject.meshSexual Dysfunction, Physiological
dc.subject.meshTime Factors
dc.titleRecommendations for follow-up of colorectal cancer survivors.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number21
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía